Nature-derived psilocybin(Psyence Biomedical)

N/A

Report date: 2025/09/03 17:52:46

Base Information

Drug NameNature-derived psilocybin(Psyence Biomedical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsNatural product/Extract
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPsyence Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesPsyence Group Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A